Interestingly, a subset of these RBFOX2 target exons is preferentially excluded across multiple cancers, including lung, breast, and colon6–10; further, these RBFOX2 target exons were shown to be alternatively spliced in ovarian and breast cancers in response to RBFOX28. This evidence concerns the gene RBFOX2 and breast carcinoma.